Literature DB >> 29624771

Assessing cognitive function in patients treated with immune checkpoint inhibitors: A feasibility study.

Stefania Cuzzubbo1,2, Catherine Belin1,2, Kader Chouahnia3, Barouyr Baroudjian4, Boris Duchemann3, Ciprian Barlog5, Giulia Coarelli5, Renata Ursu1,2, Elodie Poirier6, Celeste Lebbe4, Antoine F Carpentier1,2.   

Abstract

Entities:  

Keywords:  anti-CTLA4; anti-PD1; cancer; chemobrain; chemotherapy; cognition; immune checkpoint inhibitor; memory impairment; neurotoxicity; oncology

Year:  2018        PMID： 29624771     DOI： 10.1002/pon.4725

Source DB:  PubMed          Journal:  Psychooncology        ISSN： 1057-9249            Impact factor:   3.894


× No keyword cloud information.
  3 in total

Review 1.  Potential Effect of Immunotherapy Agents on Cognitive Function in Cancer Patients.

Authors:  Florence Joly; Hélène Castel; Laure Tron; Marie Lange; Janette Vardy
Journal:  J Natl Cancer Inst       Date:  2020-02-01       Impact factor: 13.506

Review 2.  Microglia in Cancer Therapy-Related Cognitive Impairment.

Authors:  Erin M Gibson; Michelle Monje
Journal:  Trends Neurosci       Date:  2021-03-02       Impact factor: 16.978

3.  Reintroduction of immune-checkpoint inhibitors after immune-related meningitis: a case series of melanoma patients.

Authors:  Stefania Cuzzubbo; Pauline Tetu; Sarah Guegan; Renata Ursu; Catherine Belin; Lila Sirven Villaros; Julie Mazoyer; Coralie Lheure; Celeste Lebbe; Barouyr Baroudjian; Antoine F Carpentier
Journal:  J Immunother Cancer       Date:  2020-07       Impact factor: 13.751
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.